In 1999, Dr. Emil Kakkis at Los Angeles Biomedical Research Institute (LA BioMed) developed Enzyme Replacement Therapy to…
In 1999, the Del E. Webb Center for Neuroscience and Aging, which focuses on diseases such as stroke,…
In 1999, the Delaware Biotechnology Institute was founded as a partnership among government, academia and industry to help…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
In 1999, the Fred Hutchinson Business Alliance announced that the 1999 E. Donnall Thomas Medal of Achievement would…
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
On Oct. 30, 1998, Peter Eriksson of the Salk Institute and Fred Gage of the Sahlgrenska University Hospital…
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…
In Oct. 1998, the Fetal Alcohol Syndrome Surveillance Network was created to determine the prevalence of FAS within…
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
In March 1998, the Stop TB Initiative was established following a meeting of the First Ad hoc Committee…
On Feb. 10, 1998, the Cook County Board of Commissioners took the final steps in the approval process,…
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
In 1998, Chicago Mayor Richard M. Dale proclaimed November “National Sarcoidosis Awareness Month” in Chicago. The National Sarcoidosis…
In 1998, the Cystic Fibrosis Research Center was founded at University of Iowa’s College of Medicine. Today, the…
In 1998, The University of Minnesota Cancer Center, which was founded in 1991, was renamed the Masonic Cancer…
In 1998, the The Prostate Centre at VGH, now known as the Vancouver Prostate Centre, was founded. The…
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
In 1998, University of Calgary’s Dr. Patrick Lee revealed that reovirus injected in mice shrank tumours from brain…
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
In 1998, the first phase to consolidate U.S. Food and Drug Administration (FDA) laboratories nationwide from 19 facilities…